Company Number: 14516311

Analysis Date: 2025-07-19 12:34 UTC

Financial Health Assessment for GLENN HERWEIJER LTD

---

1. Financial Health Score: B

Explanation:
GLENN HERWEIJER LTD exhibits a solid financial foundation with clear growth in assets and shareholders’ funds over the past two years. The company is managing its working capital well, maintaining a healthy margin of current assets over current liabilities. However, being a micro-entity with no employees and limited operational history, it is still in an early stage which carries inherent risks. The absence of audit due to micro-entity status does limit the depth of external assurance.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Current Assets	82,592	Increased substantially from £43,068 in 2023, indicating improved liquidity and asset base.
Current Liabilities	19,084	Grew moderately from £11,251 in 2023 but well covered by current assets, showing good short-term health.
Net Current Assets	63,508	Positive and increasing working capital indicates the company can meet its short-term obligations comfortably.
Shareholders’ Funds	63,508	Doubling from £31,817 in 2023 reflects growth in retained earnings or capital injection, enhancing financial stability.
Average Number of Employees	0	No employees yet, implying low overhead but potential limitations in operational capacity.
Company Status	Active	No signs of distress or liquidation, operating normally.
Filing Deadlines	Up to date	No overdue accounts or returns, indicating compliance and good governance.

---

3. Diagnosis

The company shows symptoms of good financial health akin to a patient with stable blood pressure and strong pulse—indicating liquidity and solvency are well maintained. The doubling of shareholders’ funds suggests capital growth or reinvestment into the business, which is a positive sign of financial vitality.

The balance sheet reveals a strong liquidity position: current assets are over four times current liabilities, indicating healthy cash flow potential and the ability to cover short-term debts without strain. This “healthy cash flow” symptom reduces the risk of financial distress.

However, the company’s micro-entity status, lack of employees, and limited operational history mean it is in a nascent phase. This is similar to a young patient who is growing well but has yet to face significant health challenges that test resilience. The absence of an audit means financial statements have not been externally verified, which is typical but suggests a need for owners to be vigilant with internal controls.

No signs of over-leverage, insolvency, or governance issues are present. The sole director, who is also the major shareholder, controls the company, which simplifies decision-making but could present concentration risk if not managed carefully.

---

4. Recommendations

1. Maintain Strong Working Capital Management: Continue prudent management of current assets and liabilities to ensure liquidity remains robust, especially as the company grows.

2. Plan for Operational Scaling: Consider hiring key personnel or outsourcing functions to avoid bottlenecks, as zero employees may limit operational efficiency and growth potential.

3. Enhance Financial Reporting: Although audit exemptions apply, voluntarily seeking periodic external financial reviews can strengthen credibility with potential investors or lenders.

4. Develop a Business Growth Strategy: As the company is in its early years, formalizing a strategic plan will help guide investment decisions and improve forecasting accuracy.

5. Monitor Director and Shareholder Risks: Since control is concentrated in one individual, implementing checks and balances such as advisory or non-executive directors can mitigate governance risks.

6. Prepare for Future Filing Deadlines: Maintain timely compliance with Companies House filings to avoid penalties and preserve corporate reputation.

---